A carregar...
Managing Pulmonary Toxicities Associated with Immunotherapy: A Case Discussion
Immunotherapy has changed the field of oncology around the world with the approval of immune checkpoint inhibitors for a number of tumor types over the last 5 years. However, immune‐mediated adverse events can be challenging and difficult to treat, with one of the most dire consequences being immune...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656522/ https://ncbi.nlm.nih.gov/pubmed/30898888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0241 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|